PD-L1 Expression is Related to Tumor Staging in NSCLC

被引：0

作者：

Wang, Hangjun

Agulnik, Jason ^{[1
,2
]}

Kasymjanova, Goulnar ^{[3
]}

Wang, Anna Y. ^{[1
,2
]}

Cohen, Victor ^{[1
,2
]}

Small, David ^{[1
,2
]}

Pepe, Carmela ^{[1
,2
]}

Sakr, Lama ^{[1
,2
]}

Fiset, Pierre O. ^{[4
]}

Auger, Manon

Camilleri-Broet, Sophie ^{[2
,4
]}

Alameldin, Mona ^{[2
,4
]}

Chong, George ^{[2
,4
]}

van Kempen, Leon ^{[2
,4
]}

Spatz, Alan ^{[2
,4
]}

机构：

[1] Jewish Gen Hosp, Montreal, PQ, Canada

[2] McGill Univ, Montreal, PQ, Canada

[3] JGH, Montreal, PQ, Canada

[4] McGill Univ, Hlth Ctr, Glen Site, Montreal, PQ, Canada

来源：

LABORATORY INVESTIGATION | 2018年 / 98卷

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

2114

引用

页码：755 / 755

页数：1

共 50 条

[21] PD-L1 in NSCLC cytology
Kovacevic, M.
Kern, I.
Gabric, S.
ANNALS OF ONCOLOGY, 2017, 28
[22] Circulating PD-L1 in NSCLC patients and the correlation between the level of PD-L1 expression and the clinical characteristics
Zhang, Jie
Gao, Jing
Li, Yanyan
Nie, Jun
Dai, Ling
Hu, Weiheng
Chen, Xiaoling
Han, Jindi
Ma, Xiangjuan
Tian, Guangming
Wu, Di
Shen, Lin
Fang, Jian
THORACIC CANCER, 2015, 6 (04) : 534 - 538
[23] Expression of PD-L1 in plasma exosomes of NSCLC patients and its associations with PD-L1 expression of corresponding tumour tissues
Yu, S.
Shi, M.
Feng, J.
ANNALS OF ONCOLOGY, 2019, 30
[24] Role of PD-L1 and Tumor Mutational Burden in NSCLC Immunotherapy
Peters, S.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S74 - S74
[25] CTLA-4 Expression in Tumor-infiltrating Lymphocytes Is Irrelevant to PD-L1 Expression in NSCLC
Muto, Satoshi
Inomata, Sho
Yamaguchi, Hikaru
Mine, Hayato
Takagi, Hironori
Ozaki, Yuki
Watanabe, Masayuki
Inoue, Takuya
Yamaura, Takumi
Fukuhara, Mitsuro
Okabe, Naoyuki
Matsumura, Yuki
Hasegawa, Takeo
Osugi, Jun
Hoshino, Mika
Higuchi, Mitsunori
Shio, Yutaka
Suzuki, Hiroyuki
ANTICANCER RESEARCH, 2021, 41 (12) : 6267 - 6272
[26] Regulation of PD-L1 expression in the tumor microenvironment
Yi, Ming
Niu, Mengke
Xu, Linping
Luo, Suxia
Wu, Kongming
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
[27] Regulation of PD-L1 expression in the tumor microenvironment
Ming Yi
Mengke Niu
Linping Xu
Suxia Luo
Kongming Wu
Journal of Hematology & Oncology, 14
[28] Longitudinal analysis of PD-L1 expression in patients with relapsed NSCLC
John, Nikolaus
Schlintl, Verena
Sassmann, Teresa
Lindenmann, Joerg
Fediuk, Melanie
Wurm, Robert
Douschan, Philipp
Zacharias, Martin
Kalson, Lipika
Posch, Florian
Absenger, Gudrun
Brcic, Luka
Jost, Philipp J.
Terbuch, Angelika
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (04)
[29] Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti-PD-L1)
Kowanetz, Marcin
Zou, Wei
Gettinger, Scott N.
Koeppen, Hartmut
Kockx, Mark
Schmid, Peter
Kadel, Edward E., III
Wistuba, Ignacio
Chaft, Jamie
Rizvi, Naiyer A.
Spigel, David R.
Spira, Alexander
Hirsch, Fred R.
Cohen, Victor
Smith, Dustin
Boyd, Zach
Miley, Natasha
Flynn, Susan
Leveque, Vincent
Shames, David S.
Ballinger, Marcus
Mocci, Simonetta
Shankar, Geetha
Funke, Roel
Hampton, Garret
Sandler, Alan
Amler, Lukas
Mellman, Ira
Chen, Daniel S.
Hegde, Priti S.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (43) : E10119 - E10126
[30] Distinct contribution of PD-L1 suppression by spatial expression of PD-L1 on tumor and non-tumor cells
Xiaoqing Zhang
Chen Cheng
Jiyan Hou
Xinyue Qi
Xin Wang
Ping Han
Xuanming Yang
Cellular & Molecular Immunology, 2019, 16 : 392 - 400

← 1 2 3 4 5 →